Should a rapid crystalloid bolus be given to children with severe infection or septic shock in low‑resource hospitals as studied in the FEAST trial?

FEAST Trial: Fluid Bolus Resuscitation in Low-Resource Settings

Direct Answer

In low-resource hospitals without intensive care availability, rapid crystalloid boluses should NOT be given to children with severe infection or septic shock unless hypotension is present. 1

Critical Context-Dependent Recommendations

For Settings WITHOUT Intensive Care (The FEAST Context)

If NO Hypotension Present:

• Do NOT give fluid boluses 1
• Start maintenance fluids only (2.5-4 mL/kg/hr)
• This is a strong recommendation with high-quality evidence based directly on the FEAST trial findings

If Hypotension IS Present:

• Administer up to 40 mL/kg in boluses (10-20 mL/kg per bolus) over the first hour 1
• Titrate to clinical markers: heart rate, blood pressure, capillary refill, consciousness level, urine output
• Stop immediately if signs of fluid overload develop (pulmonary edema, new/worsening hepatomegaly)

For Settings WITH Intensive Care Available

• Administer up to 40-60 mL/kg in boluses (10-20 mL/kg per bolus) over the first hour 1
• Same titration and stopping criteria apply

The FEAST Trial Evidence

The landmark FEAST trial 2 fundamentally changed pediatric sepsis management in resource-limited settings. This high-quality randomized controlled trial of 3,141 African children with severe febrile illness and impaired perfusion demonstrated:

• 48-hour mortality: 10.6% (albumin bolus), 10.5% (saline bolus), vs 7.3% (no bolus control)
• Relative risk of death with any bolus vs control: 1.45 (95% CI 1.13-1.86, p=0.003)
• Absolute mortality increase: 3% with fluid boluses
• Results were consistent across malaria status, severity of shock, and presence of acidosis or severe anemia

Even in the small subgroup meeting strict WHO shock criteria (n=65), boluses were harmful: 48% mortality with boluses vs 20% without (absolute risk increase of 28%) 3.

Why Boluses Are Harmful in Low-Resource Settings

The harm from fluid boluses in resource-limited settings likely stems from:

1. Lack of advanced monitoring to detect early fluid overload
2. Absence of mechanical ventilation when pulmonary edema develops
3. Different pathophysiology: Many children had malaria with microcirculatory dysfunction from parasitized erythrocyte sequestration rather than true hypovolemia 2, 4
4. Profound anemia (>50% had severe anemia), making fluid overload more dangerous
5. No rescue therapies available when complications occur

Fluid Type Selection

When fluids ARE indicated:

• Use balanced/buffered crystalloids over 0.9% saline 1

  • Reduces acute kidney injury risk 5, 6
  • Prevents hyperchloremia 6
  • Weak recommendation, very low-quality evidence for mortality benefit, but clear benefit for AKI

• Use crystalloids over albumin 1

  • No mortality difference
  • Cost considerations favor crystalloids
  • Weak recommendation, moderate-quality evidence

• Never use starches (strong recommendation) 1

• Avoid gelatin (weak recommendation) 1

Critical Clinical Pitfalls

The "Slippage" Problem

The most dangerous pitfall is "slippage" at the bedside 3. Guidelines restrict boluses to hypotensive children, but in practice, clinicians often give boluses to any child appearing unwell, exposing many to harm. Strict adherence to the hypotension criterion is essential.

Misidentifying Shock Type

• Do not rely on "warm" vs "cold" shock categorization 1
• Many African children with severe infection have microcirculatory dysfunction, not hypovolemia
• Dehydration signs (dry mucous membranes, skin tenting) are rare in acute sepsis 7

Compensated Shock Concept

The FEAST trial challenges the traditional "compensated shock" concept from high-resource settings 8. Children with impaired perfusion but normal blood pressure had worse outcomes with boluses.

Essential Concurrent Management

Fluid restriction does NOT mean withholding other critical interventions:

• Immediate appropriate antimicrobials (within 1 hour)
• Oxygen administration for hypoxemia
• Blood transfusion for severe anemia
• Treatment of underlying conditions (malaria, meningitis, pneumonia)
• Correction of hypoglycemia
• Maintenance fluid administration (not boluses)

The low overall mortality in FEAST (8.7% in control group) demonstrates that excellent supportive care with maintenance fluids and treatment of underlying conditions achieves good outcomes without aggressive boluses 4.

Monitoring During Resuscitation

Frequent reassessment is mandatory:

• Clinical markers: Heart rate, blood pressure, capillary refill time, consciousness level, urine output
• Serial lactate measurements when available 1
• Watch for fluid overload: Respiratory distress, pulmonary edema, hepatomegaly

Stop boluses immediately if any signs of fluid overload develop, even if target volume not reached.

The Bottom Line

The FEAST trial provides high-quality evidence that in resource-limited settings without intensive care, fluid boluses kill children with severe infection unless they are hypotensive. This represents a fundamental departure from high-resource protocols and must be strictly followed to prevent harm. The 2020 Surviving Sepsis Campaign guidelines 1 incorporated these findings with a strong recommendation against boluses in non-hypotensive children in low-resource settings—one of the few strong recommendations in pediatric sepsis management.